This research demonstrates our commitment to advancing radiotherapy technology. Blue Physics has developed a novel approach to small field dosimetry in the challenging environment of a 0.35 T MR-linac. By leveraging a commercial plastic scintillator detector and combining computational modeling with experimental validation, we've achieved a significant step towards improving treatment accuracy and precision for cancer patients.

This publication is a testament to Blue Physics' dedication to innovation and collaboration. We're excited to share our findings with the scientific community and explore the potential impact on cancer care.

Read the full paper here: https://lnkd.in/e_-gSf_m